227 related articles for article (PubMed ID: 19160539)
1. Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
Ranawaka RR; de Silva N; Ragunathan RW
J Dermatolog Treat; 2008; 19(5):308-12. PubMed ID: 19160539
[TBL] [Abstract][Full Text] [Related]
2. Onychomycosis caused by Fusarium proliferatum.
Hattori N; Shirai A; Sugiura Y; Li W; Yokoyama K; Misawa Y; Okuzumi K; Tamaki K
Br J Dermatol; 2005 Sep; 153(3):647-9. PubMed ID: 16120158
[TBL] [Abstract][Full Text] [Related]
3. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
Ranawaka RR; Nagahawatte A; Gunasekara TA
Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T
Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
[TBL] [Abstract][Full Text] [Related]
5. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Piraccini BM; Sisti A; Tosti A
J Am Acad Dermatol; 2010 Mar; 62(3):411-4. PubMed ID: 20159308
[TBL] [Abstract][Full Text] [Related]
7. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases.
Tosti A; Piraccini BM; Lorenzi S
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):217-24. PubMed ID: 10642676
[TBL] [Abstract][Full Text] [Related]
8. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
9. Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Baudraz-Rosselet F; Ruffieux C; Lurati M; Bontems O; Monod M
Dermatology; 2010; 220(2):164-8. PubMed ID: 20110639
[TBL] [Abstract][Full Text] [Related]
10. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
Ginter-Hanselmayer G; Weger W; Smolle J
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
[TBL] [Abstract][Full Text] [Related]
11. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
12. Management of onychomycosis in children.
Gupta AK; De Rosso JQ
Postgrad Med; 1999 Jul; Spec No():31-7. PubMed ID: 10492664
[TBL] [Abstract][Full Text] [Related]
13. Onychomycosis caused by Nigrospora sphaerica in an immunocompetent man.
Fan YM; Huang WM; Li W; Zhang GX
Arch Dermatol; 2009 May; 145(5):611-2. PubMed ID: 19451523
[No Abstract] [Full Text] [Related]
14. Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.
Aman S; Akbar TM; Hussain I; Jahangir M; Haroon TS
J Coll Physicians Surg Pak; 2003 Nov; 13(11):618-20. PubMed ID: 14700485
[TBL] [Abstract][Full Text] [Related]
15. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial.
Kaçar N; Ergin S; Ergin C; Erdogan BS; Kaleli I
Clin Exp Dermatol; 2007 Jan; 32(1):1-5. PubMed ID: 16824053
[TBL] [Abstract][Full Text] [Related]
16. Onychomycosis: report on experience with itraconazole in 37 patients aged older than 50 years: a multivariate regression.
Sadighha A; Mohagheghzahed G
Clin Exp Dermatol; 2009 Dec; 34(8):924-5. PubMed ID: 19438527
[No Abstract] [Full Text] [Related]
17. Non-dermatophyte mold onychomycosis in Sri Lanka.
Ranawaka RR; de Silva N; Ragunathan RW
Dermatol Online J; 2012 Jan; 18(1):7. PubMed ID: 22301044
[TBL] [Abstract][Full Text] [Related]
18. Non-dermatophytic onychomycosis. An understimated entity? A study of 51 cases.
Gianni C; Cerri A; Crosti C
Mycoses; 2000; 43(1-2):29-33. PubMed ID: 10838843
[TBL] [Abstract][Full Text] [Related]
19. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
Shemer A; Nathansohn N; Kaplan B; Trau H
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
[TBL] [Abstract][Full Text] [Related]
20. [The treatment of extensive onychomycosis in aged patients].
Maleszka R; Adamski Z
Wiad Parazytol; 2001; 47(4):817-22. PubMed ID: 16886433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
